Susan J. Knox
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Cancer Immunotherapy and Biomarkers, Cancer, Hypoxia, and Metabolism, Lymphoma Diagnosis and Treatment, CAR-T cell therapy research
Most-Cited Works
- → Pivotal Study of Iodine I 131 Tositumomab for Chemotherapy-Refractory Low-Grade or Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas(2001)585 cited
- → Role of glutathione depletion and reactive oxygen species generation in apoptotic signaling in a human B lymphoma cell line(2002)498 cited
- → In Situ Vaccination With a TLR9 Agonist Induces Systemic Lymphoma Regression: A Phase I/II Study(2010)482 cited
- → Multicenter Phase II Study of Iodine-131 Tositumomab for Chemotherapy-Relapsed/Refractory Low-Grade and Transformed Low-Grade B-Cell Non-Hodgkin’s Lymphomas(2000)362 cited
- Yttrium-90-labeled anti-CD20 monoclonal antibody therapy of recurrent B-cell lymphoma.(1996)
- → A Systemic Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy(2012)242 cited
- → Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas